Leucid Bio

Developer of therapeutics for the treatment of cancers

placeLondon, England, United Kingdom calendar_todayFounded 2014 groups10 employees language leucid.com

Registered entities

Social engagement

Social engagement: 4.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Epidarex Capital, Vulpes Investment Management.

Investor typeCountShare
Venture capital222%
Private equity222%
Bank & private debt111%
Other / undisclosed444%

Recent activity

12 Mar 2026
Event
Advanced Therapies Congress
9 Feb 2026
Event
IO360 Summit
5 Jan 2026
Event
44th Annual J.P. Morgan Healthcare Conference
Coming soon